Access Industries Holdings LLC - 15 Aug 2022 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
10%+ Owner
Signature
/s/ Alejandro Moreno for Access Industries Holdings LLC
Issuer symbol
VRNA
Transactions as of
15 Aug 2022
Net transactions value
+$6,300,000
Form type
4
Filing time
17 Aug 2022, 16:03:13 UTC
Previous filing
17 Aug 2022
Next filing
06 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Purchase $6,300,000 +4,800,000 +9.4% $1.31 55,911,648 15 Aug 2022 By AI Biotechnology LLC F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight ordinary shares of the Issuer.
F2 The price reported represents the purchase price of the ADSs divided by eight.
F3 The securities reported are held directly by AI Biotechnology LLC ("AIB") and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because Len Blavatnik controls AIM and controls a majority of the outstanding voting interests in AIH, AIM controls AIH, and AIH controls all of the outstanding voting interests in AIB. Each of the reporting persons (other than AIB) disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.